Previous 10 | Next 10 |
Gainers: Atossa Genetics (NASDAQ: ATOS ) +28% . Immunic (NASDAQ: IMUX ) +22% . Akari Therapeutics (NASDAQ: AKTX ) +19% . Superconductor Technologies (NASDAQ: SCON ) +18% . X4 Pharmaceuticals (NASDAQ: XFOR ) +17% . Hasbro (NASDAQ: HAS ) +16% . Twitter (NYSE: TWTR ) +16% . Trova...
TrovaGene (NASDAQ: TROV ) +22% on positive onvansertib data . More news on: TrovaGene, Inc., Akari Therapeutics, Plc, Hasbro, Inc., Stocks on the move, Read more ...
SAN FRANCISCO, CA / ACCESSWIRE / April 22, 2019 / According to The American Cancer Society ( ACS ) breast cancer is the most common cancer in American women, except for skin cancers. Currently, the average risk of a woman in the United States developing breast cancer sometime in her life is ...
SEATTLE, April 22, 2019 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ: ATOS ), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, today announced that Steven C. Quay, M.D., Ph.D., Atossa...
Atossa Genetics (NASDAQ: ATOS ): FY GAAP EPS of -$5.50 misses by $0.47. Cash and cash equivalents of $10.38M Press Release More news on: Atossa Genetics Inc., Earnings news and commentary, Healthcare stocks news, ,
SEATTLE, March 28, 2019 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (Nasdaq:ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, today announced year end 2018 financial results and provided an u...
Data by YCharts Atossa Genetics ( ATOS ) has become a very exciting story for investors in recent months. Our recent article provides some fundamental background information on the company. The marketplace has a growing awareness of the cautious optimism building among the families and p...
SAN FRANCISCO, CA / ACCESSWIRE / March 27, 2019 / Vista Partners ("Vista") has published March 2019's FREE Macroeconomic & Investment Monthly Newsletter, "Bull Market Hopping?" Vista's monthly newsletter contains macroeconomic views & investment considerations that center around V...
Aldeyra Therapeutics (NASDAQ: ALDX ) +59% on positive reproxalap data . More news on: Aldeyra Therapeutics, Inc., Hunter Maritime Acquisition Corp., Bed Bath & Beyond Inc., Stocks on the move, Read more ...
SEATTLE, March 26, 2019 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, today announced that the Institutional Review Board (IRB) has ap...
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...